Jingwei Tian

机构：Sun Yat-sen University, Sun Yat-sen Memorial Hospital · ORCID：0000-0002-3877-0903

发表论文 68 篇 · 总被引 1417 次 · h-index 23

代表论文

• A small-molecule inhibitor of MDMX suppresses cervical cancer cells via the inhibition of E6-E6AP-p53 axis (2022 · Pharmacological Research · 被引 39)
• mTOR pathway: A key player in diabetic nephropathy progression and therapeutic targets (2024 · Genes & Diseases · 被引 16)
• LPM3770277, a Potent Novel CDK4/6 Degrader, Exerts Antitumor Effect Against Triple-Negative Breast Cancer (2022 · Frontiers in Pharmacology · 被引 15)
• Unraveling DDIT4 in the VDR-mTOR pathway: a novel target for drug discovery in diabetic kidney disease (2024 · Frontiers in Pharmacology · 被引 13)
• Efficacy and dose–response relationships of antidepressants in the acute treatment of major depressive disorders: a systematic review and network meta-analysis (2024 · Chinese Medical Journal · 被引 11)
• Discovery of Novel Antitumor Small-Molecule Agent with Dual Action of CDK2/p-RB and MDM2/p53 (2024 · Molecules · 被引 9)